ACOGF Stock
Price Chart
ACOGF Financial and Trading Overview
stock price | 5.73 |
Previous Close | 0.18 |
Open | 0.18 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.18 - 0.18 |
52 Week Range | 0.15 - 0.68 |
Volume | 1K |
Avg. Volume | 2.07K |
Market Cap | 17.28M |
Beta (5Y Monthly) | 2.874433 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.25 |
ACOGF Valuation Measures
Enterprise Value | 12.93M |
Trailing P/E | N/A |
Forward P/E | 1.1250001 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 12.000001 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.044 |
Trading Information
Stock Price History
Beta (5Y Monthly) | 2.874433 |
52-Week Change | -59.54% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.68 |
52 Week Low | 0.15 |
50-Day Moving Average | 0.18 |
200-Day Moving Average | 0.25 |
ACOGF Share Statistics
Avg. Volume (3 month) | 2.07K |
Avg. Daily Volume (10-Days) | 1.7K |
Shares Outstanding | 86.9M |
Float | 62.63M |
Short Ratio | N/A |
% Held by Insiders | 20.95% |
% Held by Institutions | 11.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -101.82% |
Return on Equity (ttm) | -270.77% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -12384357 |
Net Income Avi to Common (ttm) | -11062846 |
Diluted EPS (ttm) | -0.16 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.88M |
Total Cash Per Share (mrq) | 0.05 |
Total Debt (mrq) | 1.17M |
Total Debt/Equity (mrq) | 88.51 |
Current Ratio (mrq) | 2.035 |
Book Value Per Share (mrq) | 0.015 |
Cash Flow Statement
Operating Cash Flow (ttm) | -9254083 |
Levered Free Cash Flow (ttm) | -4274150 |
Profile of
Country | United States |
State | BC |
City | Vancouver |
Address | 301–1228 Hamilton Street |
ZIP | V6B 6L2 |
Phone | 604-564-9244 |
Website | https://www.alphacognition.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
Q&A For Stock
What is a current ACOGF stock price?
ACOGF stock price today per share is 5.73 .
How to purchase stock?
You can buy ACOGF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is ACOGF.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.